New York, NY, February 17, 2015 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the International Society of Nephrology (ISN), the global medical society devoted to advancing kidney care worldwide, announced today that Elsevier will publish ISN's flagship journals, Kidney International and Kidney International Supplements, as of January 1, 2016.
Now in its 43rd year of publication, Kidney International is one of the most highly cited journals in nephrology and widely regarded as one of the world's premier journals on the development and consequences of kidney disease. It is led by Editor-in-Chief Detlef Schlondorff, MD, Mount Sinai Medical Center, New York, NY, and supported by a world-class editorial board. The journal publishes peer-reviewed original research in both basic science and clinical medicine covering renal physiology, biochemistry, pathology, immunology, morphology, complications of chronic kidney disease, treatment by dialysis and kidney transplantation, and more. Kidney International Supplements is a peer-reviewed companion journal to Kidney International publishing sponsored, topical content of interest to the nephrology community.
David Harris, ISN's Publications Committee Chair, said, "I am delighted that ISN managed to find a great publisher in Elsevier. Considering the big changes happening in the field of medical publishing, it is very reassuring that Kidney International is such an attractive journal to Elsevier. Even more important for our not-for-profit society is the fact that royalties from Kidney International contribute a large part of our philanthropic activities' budget."
"Elsevier is delighted and honored to be partnering with ISN in the publication of their highly respected journals," commented Elsevier's Anne Kitson, Executive Vice President, Health and Medical Sciences Journals. "We are excited to have the opportunity to work with ISN and the editorial team to ensure continued success of both journals and to explore new avenues for collaboration."
About International Society of Nephrology
Established in 1960, the International Society of Nephrology (ISN) is a not-for-profit society whose mission is the global advancement of nephrology. The ISN is dedicated to advancing the diagnosis, treatment, and prevention of kidney diseases in the developing and developed world by raising public awareness of the importance of early recognition and treatment of kidney diseases; connecting professionals interested in kidney and related diseases around the world; supporting research to achieve optimal care of people with kidney diseases; providing nephrology education and training worldwide; and, ultimately, reducing the frequency and impact of kidney diseases and their associated conditions. For more information: http://www.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes nearly 2,200 journals, including The Lancet and Cell, and over 33,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+1 215 239 3798
International Society of Nephrology
+32 2 8080 420
+1 567 248 9703